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The Beneﬁcial Tip of a Troublesome Iceberg*Arthur J. Moss, MD, Valentina Kutyifa, MD, PHDSEE PAGE 2581I mplantation of transvenous pacemakers began inthe 1960s, and currently several million patientsworldwide are living with a life-saving implanted
pacemaker. The implanted cardioverter-deﬁbrillator
(ICD) was ﬁrst reported in 3 patients in 1980 (1), with
a marked and progressive increase in the number
of implanted devices beginning in the mid-1980s.
Implantation of cardiac resynchronization therapy
(CRT) with and without an ICD began in the mid-
1990s, with an increase in application of this effective
treatment beginning at the turn of the century. Most
of these devices have been implanted in older patients,
generally in those >65 years of age, who are likely to
have noncardiac as well as cardiac problems. During
the 50-year period from 1965 to 2015, new diagnostic
techniques were introduced, including magnetic reso-
nance imaging (MRI), which is widely used for diag-
nosis and evaluation of patients with cardiac and
noncardiac disorders. However, the use of MRI diag-
nostics in patients with implanted devices has
remained a controversial issue to the present day.
Early on, it was appreciated that MRI could
adversely affect the electrical function of implanted
transvenous pacemakers, ICDs, and CRTs, and several
deaths were reported during MRI scanning in patients
with these implanted devices (2). By way of back-
ground (3), the main magnetic coils of an MRI system*Editorials published in the Journal of the American College of Cardiology
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which is measured in Tesla units—a unit of magnetic
ﬂux density. Inside the main magnet are 3 gradient
coils that generate on/off magnetic ﬁelds. The static
and dynamic electrical ﬁelds of the MRI can affect the
electronic circuits and settings of pacemakers, ICDs,
and CRT devices. Most clinical MRI systems operate
at 1.5-T, but an increasing number of MRI systems are
using 3.0-T output, an amount of magnetic ﬁeld
strength that provides better imaging but is likely to
have a greater adverse effect on implanted electrical
devices.
The reed switch in a pacemaker or an ICD is un-
predictably affected by the electric ﬁeld generated by
the MRI with resultant pacemaker, ICD, or CRT mal-
function. Recently, several device manufacturers
have developed MRI conditional pacemakers and
ICDs that allow for safe MRI scanning with limited
exposure in patients with these implanted units (3).
At the present time, there is only limited experience
with MRI in patients with CRT.In reviewing the published medical data on this
MRI-device topic, almost all of the published papers
were experiential studies involving a limited number
of patients with no control group and little or no in-
formation after MRI scanning in the device-implanted
patients. In this issue of the Journal, Gold et al. (4)
report the ﬁrst international, multicenter, prospec-
tive, randomized trial evaluating the safety of 1.5-T
full-body MRI exposure (chest, cervical, and head
regions) in 175 ICD patients, including patients
with single- or dual-chamber ICD devices, and with a
control group of 88 ICD patients not exposed to
MRI. The ICD involved a Medtronic Evera MRI-ICD
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2590(Medtronic, Minneapolis, Minnesota) connected to
commercially-available Medtronic deﬁbrillator leads.
The endpoints included ventricular pacing threshold,
decrease in R-wave amplitude, and a limited number
of induced and spontaneous ventricular tachycardia/
ventricular ﬁbrillation episodes during a 1-month
follow-up. The primary ﬁndings were the absence of
adverse effects with the standardized, comprehensive
MRI protocol. Pacing and sensing were not signiﬁ-
cantly affected by MRI, with normal arrhythmia
detection and deﬁbrillation function documented
during and following the MRI examinations.
The Medtronic Evera MRI-ICD was speciﬁcally
designed to reduce interaction between the ICD and
the MRI-induced electrical environment, and such
electronic devices are categorized as “conditional”
(i.e., conditioned to work properly in an MRI envi-
ronment). As described by Gold et al. (4) in the cur-
rent paper, the following modiﬁcations were included
in the Medtronic Conditional Evera MRI-ICD utilized
in the trial: “ferromagnetic material was reduced, a
hall sensor replaced the mechanical reed switch, ﬁl-
ters to prevent gradient and radiofrequency (RF) were
added, and battery circuitry protection was added.”
Pre-clinical testing substantiated the safety of this
system (5). Other manufacturers have developed
MRI-compatible pacemakers, but only Biotronik
(Berlin, Germany) has developed ICDs that can be
used during MRI scanning, as long as it does not
involve chest scanning (3).
It is clear that new upgrades of the ICD are
becoming safer in patients undergoing MRI studies. It
is only a matter of time before all cardiac electronic
device manufacturers will have MRI-compatible
pacemakers, ICDs, and CRTs available for use with
both 1.5- and 3.0 T-MRI, and possibly higher, but that
does not exist now. Furthermore, there are large
numbers of cardiac electronic devices already
implanted that are susceptible to the adverse effects
of the generated electromagnetic ﬁelds associated
with the current generation of MRI techniques.So, where does that leave us now? Reasonable
programming guidance is provided for conventional
(nonconditional) implanted pacemaker or deﬁbril-
lator devices during MRI in the 2013 European
Society of Cardiology (ESC) guidelines (6): 1) pa-
tients who are not pacemaker dependent should
be programmed to VVI/DDI (inhibited mode); and
2) patients who are pacemaker dependent should
be programmed to VOO/DOO (asynchronous mode).
In addition, it is recommended to deactivate other
pacing functions, deactivate monitoring and anti-
tachycardia pacing/shock functions in ICDs, monitor
electrocardiography and symptoms during MRI,
restore original device programming, and check the
device function after the MRI. For patients with
MRI-compatible pacemakers or ICDs such as re-
ported by Gold et al. (4) and by other investigators,
one should follow the manufacturer’s instructions.
Presently, there are no speciﬁc validated guidelines
for patients with implanted cardiac resynchroniza-
tion devices, but ﬁxed rate VOO pacing with
other parameters turned off in patients who are
not pacemaker dependent would seem reasonable.
Additional helpful suggestions are provided in the
ESC guidelines (6).
The trial by Gold et al. (4) has signiﬁcantly
advanced safe MRI studies using 1.5-T output in pa-
tients with the new, conditional ICD. This approach is
the beneﬁcial tip of a troublesome iceberg. Millions
of patients worldwide have nonconditional devices
implanted, and MRI scanning techniques at 1.5-T and
above are currently in use, with the full effects on
existing cardiac electrical devices yet to be deter-
mined. There are many issues still to be resolved, but
such is the future of medicine.
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